• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9548
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Vascular Dissection (3160)
Event Date 06/26/2023
Event Type  Injury  
Event Description
It was reported that the patient experienced dissection and hematoma requiring additional intervention.A 12 x 2.50 promus premier drug-eluting stent (des) was selected for treatment.However, during the procedure, dissection and hematoma appeared at the edge of the blood vessel where the unexpanded stent was placed.The device was withdrawn and the procedure was completed with a wolverine cutting balloon and a new stent was implanted.It was noted that the cause of the event was related to the patient's own issue.No further patient complications were reported.
 
Manufacturer Narrative
E1: initial reporter address 1: (b)(6).E1: initial reporter phone: (b)(6).
 
Manufacturer Narrative
(b)(6).Device evaluated by mfr: promus premier ous mr 12 x 2.50mm stent delivery system (sds) was returned to the complaint investigation site (cis).Visual, tactile and microscopic analysis was performed on the device.No issues identified with the hypotube shaft.No issues identified with the outer / mid-shaft sections or the inner lumen of the device.There was no sign of damage, stretching or lifting of the stent struts.Balloon cones were reviewed, and no issues were noted.Balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.No signs of movement, stent was set between the proximal and distal markerbands.Bumper tip showed no signs of distal tip damage.
 
Event Description
It was reported that the patient experienced dissection and hematoma requiring additional intervention.A 12 x 2.50 promus premier drug-eluting stent (des) was selected for treatment.However, during the procedure, dissection and hematoma appeared at the edge of the blood vessel where the unexpanded stent was placed.The device was withdrawn, and the procedure was completed with a wolverine cutting balloon and a new stent was implanted.It was noted that the cause of the event was related to the patient's own issue.No further patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17579884
MDR Text Key321510833
Report Number2124215-2023-40951
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 11/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9548
Device Catalogue Number9548
Device Lot Number0030130857
Was Device Available for Evaluation? Device Returned to Manufacturer
Initial Date Manufacturer Received 07/27/2023
Initial Date FDA Received08/18/2023
Supplement Dates Manufacturer Received11/02/2023
Supplement Dates FDA Received11/21/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/05/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-